Dahua Intelligence: After this non-public offering, Fujian Haosheng and Chen Rongsheng will hold a total of 27.19% of Dahua Intelligence. Fujian Haosheng is the controlling shareholder of the company, and Chen Rongsheng is the actual controller of the company.
Shanghai Tianyang: In the first quarter, the price of photovoltaic EVA particles has been greatly reduced compared with the fourth quarter of last year, and it has basically returned to the level of the fourth quarter of last year.
Gaohong Co., Ltd.: It is planned to raise no more than 1.529 billion yuan, which will be used for industrial Internet product research and development and operation service system construction projects, and Nantong Yunshu 100% equity acquisition project.
Guangdong Hongtu: The company received a designated development notice from Xiaopeng Motors, and Xiaopeng Motors decided to choose the company as a supplier of integrated structural parts for a certain model of the chassis.
Oceanwide Holdings: The Beijing Financial Court froze the company’s 31.03% stake in Minsheng Securities for a period of three years.
Chuanneng Power: It is planned to form a joint venture company with Yiwei Lithium Energy and Honeycomb Energy to invest in the construction of a 30,000-ton/year lithium salt project with a total investment of 1.491 billion yuan. The newly established joint venture company has a registered capital of 750 million yuan, of which the company invested 383 million yuan, with a shareholding ratio of 51%.
CICC: Shareholder Haier Jinying plans to reduce its holdings of A shares by no more than 2.8%.
Jinshi Resources: The holding subsidiary plans to invest in a comprehensive resource utilization fluorine chemical supporting project with an annual output of 2X400,000 tons of sulfuric acid, with a total investment of 494 million yuan.
China National Nuclear Corporation: In May, the company’s cumulative operating income was 40.966 billion yuan, a year-on-year increase of 23.68%; the cumulative new contracts were 52.743 billion yuan, a year-on-year decrease of 1%.
Western Gold: It has not signed or negotiated major contracts recently, and has not invested in new projects for industrial transformation and upgrading. There are no major issues that should be disclosed but not disclosed.
BYD: CITIC Securities, GF Securities, Changjiang Securities and other securities companies have lowered the BYD financing conversion rate to 0%
Junshi Bio: JS113, the fourth-generation EGFR inhibitor, has received a drug clinical trial approval notice, which is intended to be used for the treatment of EGFR-mutant non-small cell lung cancer and other solid tumors.
Junda Shares: It plans to participate in the bidding for 33.97% equity of Jietai Technology, and the listed transfer base price is 1.053 billion yuan; the company has completed the acquisition of 51% equity. If this bid is successful, the company will hold 84.97% equity of Jietai Technology.
Watson Bio: Shanghai Zerun, a subsidiary, will concentrate its advantageous resources to promote the WHO PQ pre-qualification of bivalent HPV vaccine, clinical research of 9-valent HPV vaccine, clinical research of recombinant new crown vaccine at home and abroad, etc., and decided to terminate the clinical research of recombinant EV71 vaccine.
Tianci Materials: As of June 13, the company has repurchased 7,217,100 company shares in total, accounting for 0.375% of the company’s total share capital. The cumulative repurchase amount is 353 million yuan, accounting for 70.51% of the estimated repurchase amount.
Shanghai Electric Power: Won the bid for China Tower Zhejiang Branch’s 2022 photovoltaic new energy cooperation service procurement project, and successfully locked the 62MW distributed photovoltaic development right of China Tower base station. The project plans to build about 62MW of distributed photovoltaics, using the DC micro-grid power supply technology to provide green power for the tower base station, and the power generation can be 100% consumed.
China Chemical: From January to May, the company’s cumulative operating income was 59.739 billion yuan, a year-on-year increase of 38.05%; the cumulative new contract value was 139.827 billion yuan, a year-on-year increase of 59.28%.
Well-off shares: Dongfeng Motor Group Co., Ltd. transferred 1.1765% of its shares to foreign long-term investment institutions through block transactions.
Betta Pharmaceuticals: It plans to raise no more than 1 billion yuan from the actual controller.Return to Sohu, see more
Editor:
Disclaimer: The opinions of this article only represent the author himself, Sohu is an information publishing platform, and Sohu only provides information storage space services.